The trademark application TRINZI was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on October 7, 2020, and it was registered by office on January 14, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).